華興資本控股(01911.HK):預計年度業績轉虧為盈至約2.5億元
格隆匯3月12日丨華興資本控股(01911.HK)發佈公告,集團預期截至2019年12月31日止年度錄得公司擁有人應占利潤約3580萬美元(約2.468億人民幣),而2018年同期錄得虧損為約2.441億美元(約16.194億人民幣)。
公告表示,集團轉虧為盈主要由於2018年度期間可轉換可贖回優先股的公允價值產生變動約2.923億美元(約19.394億人民幣)。如公司此前公告所述,該等可轉換可贖回優先股已於緊接2018年9月27日公司上市前悉數轉換為公司普通股,且該等公允價值變動屬上市的一次性非營運事件,故上市日期後不會再出現因可轉換可贖回優先股的公允價值變動導致的類似會計核算虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.